FutureWise analysis estimates the biomarker market at $59.1 billion in 2023, with projections to reach $148.64 billion by 2031, growing at a CAGR of 12.20%. This growth is supported by the adoption of precision medicine, increased use of biomarkers in diagnostics and drug development, and advancements in genomics, proteomics, and digital health technologies.
Uploaded 11 months ago
Direct links
Image link
Image URL
Full image (linked)
Website (HTML)
Forums (BBCode)
Share image
Image information:
FutureWise analysis estimates the biomarker market at $59.1 billion in 2023, with projections to reach $148.64 billion by 2031, growing at a CAGR of 12.20%. This growth is supported by the adoption of precision medicine, increased use of biomarkers in diagnostics and drug development, and advancements in genomics, proteomics, and digital health technologies.